| Hang Seng Index | 25.820 HKD | +0.020 | +0.078% | 318.96M | 8.24B | 26.118 (-1.139%) HKD as at 2025/08/13 | | |
| Hang Seng China Enterprises | 92.940 HKD | +0.540 | +0.584% | 80.44M | 7.47B | 93.640 (-0.747%) HKD as at 2025/08/13 | | |
| Hang Seng TECH Index | 5.515 HKD | +0.065 | +1.193% | 886.64M | 4.88B | 5.531 (-0.296%) HKD as at 2025/08/13 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng TECH Index | 5.645 HKD | +0.140 | +2.543% | 93.70M | 527.05M | 5.696 (-0.901%) HKD as at 2025/08/13 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng TECH Index | 1.508 HKD | -0.040 | -2.584% | 152.39M | 230.45M | 1.501 (+0.480%) HKD as at 2025/08/13 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng Index | 5.820 HKD | +0.025 | +0.431% | 14.42M | 83.89M | 5.974 (-2.579%) HKD as at 2025/08/13 | | |
| Hang Seng TECH Index | 5.605 HKD | +0.075 | +1.356% | 14.52M | 81.18M | 5.617 (-0.205%) HKD as at 2025/08/13 | | |
| Hang Seng TECH Index | 11.840 HKD | +0.150 | +1.283% | 6.67M | 78.86M | 11.866 (-0.221%) HKD as at 2025/08/13 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng Index | 1.972 HKD | -0.008 | -0.404% | 34.28M | 67.58M | 1.923 (+2.532%) HKD as at 2025/08/13 | | |
| CSI 300 | 48.040 HKD | +0.700 | +1.479% | 972.16K | 46.38M | 47.219 (+1.738%) HKD as at 2025/08/13 | | |
| Hang Seng China Enterprises | 10.730 HKD | +0.020 | +0.187% | 4.06M | 43.55M | 10.715 (+0.144%) HKD as at 2025/08/13 | | |
| CME CF Ether-Dollar Reference Rate - Asia Pacific Variant | 10.360 HKD | -0.730 | -6.583% | 3.57M | 37.56M | 11.091 (-6.593%) HKD as at 2025/08/13 | | |
| FTSE China A50 | 15.270 HKD | +0.190 | +1.260% | 1.14M | 17.26M | 15.076 (+1.286%) HKD as at 2025/08/13 | | |
| Hang Seng Hong Kong-Listed Biotech Index | 17.620 HKD | +0.160 | +0.916% | 973.50K | 17.18M | 16.950 (+3.954%) HKD as at 2025/08/13 | | |
| FTSE China A50 | 14.220 HKD | +0.130 | +0.923% | 1.19M | 16.84M | 14.040 (+1.286%) HKD as at 2025/08/13 | | |
| CSI 300 | 31.460 HKD | +0.480 | +1.549% | 425.90K | 13.32M | 30.930 (+1.712%) HKD as at 2025/08/13 | | |
| MSCI India Net Total Return (USD) Index | 6.965 HKD | +0.130 | +1.902% | 1.71M | 11.86M | 6.899 (+0.952%) HKD as at 2025/08/13 | | |
| London Gold Fixing Price | 2,411.000 HKD | +1.000 | +0.041% | 4.58K | 11.05M | N/A | | |
| CME CF Bitcoin Reference Rate- Asia Pacific Variant | 14.230 HKD | -0.410 | -2.801% | 674.40K | 9.65M | 14.759 (-3.583%) HKD as at 2025/08/13 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | ChiNext Index (HKD)(CNH) | 5.455 HKD | +0.315 | +6.128% | 1.80M | 9.51M | 5.048 (+8.067%) HKD as at 2025/08/13 | | |
| FTSE US Treasury 20+ Years Index | 67.800 HKD | -0.240 | -0.353% | 136.56K | 9.25M | 68.765 (-1.404%) HKD as at 2025/08/13 | | |
| Hang Seng High Dividend Yield | 30.360 HKD | -0.080 | -0.263% | 300.07K | 9.11M | 30.643 (-0.923%) HKD as at 2025/08/13 | | |
| CME Bitcoin Futures | 38.900 HKD | -1.160 | -2.896% | 188.40K | 7.38M | 41.578 (-6.442%) HKD as at 2025/08/13 | | |
| ChiNext Index | 10.040 HKD | +0.390 | +4.041% | 515.60K | 5.09M | 9.577 (+4.839%) HKD as at 2025/08/13 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | CSI 300 | 4.240 HKD | +0.116 | +2.813% | 1.06M | 4.45M | 4.106 (+3.276%) HKD as at 2025/08/13 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | NASDAQ-100 Index | 3.670 HKD | +0.020 | +0.548% | 1.18M | 4.32M | 3.662 (+0.218%) HKD as at 2025/08/13 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng China Enterprises | 3.560 HKD | +0.034 | +0.964% | 1.06M | 3.77M | 3.623 (-1.731%) HKD as at 2025/08/13 | | |
| CSI 300 | 44.100 CNY | +0.600 | +1.379% | 86.00K | 3.76M | 43.212 (+2.054%) CNY as at 2025/08/13 | | |
| Hang Seng Index | 23.700 CNY | -0.020 | -0.084% | 154.50K | 3.66M | 23.886 (-0.777%) CNY as at 2025/08/13 | | |
| CME CF Ether-Dollar Reference Rate - Asia Pacific Variant | 3.328 HKD | -0.272 | -7.556% | 1.07M | 3.61M | 3.562 (-6.577%) HKD as at 2025/08/13 | | |